Pharmaceutical Policy

Answer Letter from FDA CDER to Edward L. Klaiber, M.D.

Answer Letter from FDA CDER to George Washington University

Answer Letter from FDA CDER to The Emory Clinic, Inc.

Answer Letter from FDA CDER to Mayo Clinic

Answer Letter from FDA CDER to General Clinical Research Center

Answer Letter from FDA CDER to USC School of Medicine Women's Hospital

Hearing request from Alston & Bird LLP (on behalf of ANI Pharmaceuticals, Inc.)

Hearing request from Hyman, Phelps & Mcnamara, P.C. (on behalf of Syntho Pharmaceutical, Inc.)

Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661

Acknowledgment Letter from FDA DMB to Frommer Lawrence & Haug, L.L.P.

Acknowledgment Letter from FDA DMB to Frommer Lawrence & Haug, L.L.P.

Letter from FDA CDER to Frommer Lawrence & Haug, L.L.P.